Benzinga | Nov 17, 2020 04:31PM EST

Aeglea BioTherapeutics To Participate In Two Upcoming Virtual Investor Conferences Nov. 23 And Dec. 1

AUSTIN, Texas, Nov. 17, 2020 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare and other high-burden diseases, today announced it will participate in fireside chats at two investor conferences in December 2020.

Conference Details

Conference Name: Piper Sandler 32nd Annual Virtual Healthcare Conference

Conference Date: November 30 - December 3, 2020

Fireside Chat Date/Time: Available beginning November 23, 2020

Presenter: Anthony G. Quinn, M.B. Ch.B., Ph.D., Aeglea's president and chief executive officer

Conference Name: Evercore ISI 3rd Annual HealthCONx Conference

Conference Date: December 1-3, 2020

Fireside Chat Date/Time: December 1, 2020 at 4:20 p.m. EST

Presenter: Anthony G. Quinn, M.B. Ch.B., Ph.D., Aeglea's president and chief executive officer

To access the live and archived webcasts, visit the Presentations & Events section of the Company's website. Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. An archived version of the webcasts will also be available through the Company's website for a limited time following the conferences.